The Firm is representing Teleflex Incorporated (NYSE: TFX) in connection with its acquisition of Vascular Solutions, Inc. (NASDAQ: VASC) for $56 in cash per share, for a transaction valued at approximately $1 billion.
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. Teleflex applies purpose driven innovation - a relentless pursuit of identifying unmet clinical needs - to benefit patients and healthcare providers. Teleflex’s portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care.
The Simpson Thacher team includes Mario Ponce, Ravi Purushotham and Alex Cushman (M&A); William Sheehan and Christian Fischer (Banking and Credit); Roxane Reardon, Lia Toback and Joia Lee (Capital Markets); Larry Moss, Eric Wolf and Christopher Scavone (Executive Compensation and Employee Benefits); John Creed and Sarah Katz (Tax); Lori Lesser (Intellectual Property); Michael Isby (Environmental); and Peter Guryan and Karen Horvitz (Antitrust).